---
title: "Fishman - Mark Charles — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4e1ba460-7bc0-5f07-86f2-59c99c548b16
json: https://whiteintel.dev/api/public/dossier/4e1ba460-7bc0-5f07-86f2-59c99c548b16
identifier: icij:icijol-80065700
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Fishman - Mark Charles

**Type:** Organization  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `icij:icijol-80065700`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4e1ba460-7bc0-5f07-86f2-59c99c548b16  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4e1ba460-7bc0-5f07-86f2-59c99c548b16  

## Ownership & control

### Holdings / subsidiaries

- **Novartis International Pharmaceutical Ltd.** (director of) — https://whiteintel.dev/entity/9c3dc033-206c-5680-a45d-08248339f7d8

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/80065700

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Fishman - Mark Charles**. Human view: https://whiteintel.dev/entity/4e1ba460-7bc0-5f07-86f2-59c99c548b16 · Structured JSON: https://whiteintel.dev/api/public/dossier/4e1ba460-7bc0-5f07-86f2-59c99c548b16._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._